Evidence map›Paper›PMID 39012856›Full record

ArticlePLOS global public health2024

Identifying the strains of dengue circulating in the western province of Sri Lanka during 2019-2022.

Harshi Abeygoonawardena, Kanchana Dassanayake, Jayani Kariyawasam, Teshan Chathuranga, Tharmini Sundralingam, Hansani Gunasekara, Sathyani Wevita, Gayani Premawansa, Sunil Premawansa, Ananda Wijewickrama and 6 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Harshi AbeygoonawardenaFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.
Kanchana DassanayakeFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.
Jayani KariyawasamFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.
Teshan ChathurangaFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.
Tharmini SundralingamGenelabs Medical (Pvt) Ltd, Nawala Rd, Nawala, Sri Lanka.
Hansani GunasekaraFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.
Sathyani WevitaFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.
Gayani PremawansaColombo North Teaching Hospital, Ragama, Sri Lanka.
Sunil PremawansaFaculty of Science, University of Colombo, Colombo, Sri Lanka.
Ananda WijewickramaNational Institute of Infectious Diseases, Angoda, Sri Lanka.
Namal WijesingheFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.
Varuna NavaratneFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.
Daniela WeiskopfLa Jolla Institute for Immunology, Center for Infectious Disease and Vaccine Research, La Jolla, California, United States of America.ORCID https://orcid.org/0000-0003-2968-7371
Alessandro SetteLa Jolla Institute for Immunology, Center for Infectious Disease and Vaccine Research, La Jolla, California, United States of America.ORCID https://orcid.org/0000-0001-7013-2250
Chandanamali PunchihewaGenelabs Medical (Pvt) Ltd, Nawala Rd, Nawala, Sri Lanka.
Aruna Dharshan De SilvaFaculty of Medicine, General Sir John Kotelawala Defence University, Kandawala Estate Ratmalana, Sri Lanka.ORCID https://orcid.org/0000-0001-5291-9543

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A study conducted from July 2019 to May 2022 at several hospitals in the Western Province, Sri Lanka, focused on dengue virus strains during the COVID-19 pandemic. Among 417 febrile patients, 47% were PCR-positive for dengue. Serotyping revealed DENV-1 (12.8%), DENV-2 (46.4%), DENV-3 (37.2%), and DENV-4 (3.6%). Sequencing identified two genotypically distinct variants of DENV-3 and two genotypically distinct variants of DENV-1, while DENV-2 showed a single genotype cluster. Notably, the study found concurrent circulation of two DENV-3 and two DENV-1 genotypes, along with DENV-2, during the pandemic in the area. This data suggests the presence of multiple dengue strains, including several DENV-1 and DENV-3 variants, without major epidemic outbreaks reported in the Western Province. Continuous monitoring and research are essential to understand the dynamics of these dengue strains in the context of the COVID-19 pandemic.

Identifiers

PMID39012856
PMCPMC11251588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.